{"sector":{"0":"Healthcare"},"longName":{"0":"J. B. Chemicals & Pharmaceuticals Limited"},"fullTimeEmployees":{"0":4340},"longBusinessSummary":{"0":"J. B. Chemicals & Pharmaceuticals Limited manufactures and markets various pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients in India and internationally. Its principal products include Cilnidipine, Ranitidine, and Metronidazole. The company also provides contract manufacturing services for tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups, and capsules; and soft-centered, powder, medicated, and herbal lozenges, as well as various pharmaceutical dosage forms. In addition, it offers a range of contrast media products, including x-ray, magnetic resonance imaging (MRI), and ultrasound scanners. Further, the company provides its services in gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance therapeutic areas. J. B. Chemicals & Pharmaceuticals Limited was incorporated in 1976 and is based in Mumbai, India."},"city":{"0":"Mumbai"},"phone":{"0":"91 22 2439 5200"},"website":{"0":"https:\/\/www.jbpharma.com"},"grossProfits":{"0":15587907000},"totalCash":{"0":566502976},"totalDebt":{"0":545587968},"totalRevenue":{"0":26030637056},"totalCashPerShare":{"0":7.33},"revenuePerShare":{"0":336.831},"bookValue":{"0":210.343},"priceToBook":{"0":9.244425},"marketCap":{"0":152572854272},"averageVolume":{"0":69749},"fiftyTwoWeekHigh":{"0":2150},"fiftyTwoWeekLow":{"0":1342.2},"logo_url":{"0":"https:\/\/logo.clearbit.com\/jbpharma.com"}}